Quantum Blue - Calprotectin Lateral Flow Assay
The Quantum Blue® Calprotectin lateral flow assay combines the ease and speed of lateral flow technology (using a highly specific monoclonal antibody to calprotectin), with full quantification by means of a small, telephone sized reading device. The Quantum Blue® Reader analyzes the signal intensity from the test and control line to give a quantitative value and is standardized with the BÜHLMANN fCAL® ELISA.
Quantum Blue® fCAL Assays are for Research Use Only. Not for use in diagnostic procedures in the US.
Quantum Blue® Reader: Health Canada Licence: 83478
Quantum Blue® fCAL: Health Canada Licence: 83477
Quantum Blue® fCAL extended: Health Canada Licence: 100161
Quantum Blue® fCAL high range: Health Canada Licence: 88674
Quantum Blue® Adalimumab: Health Canada Licence: 101776
Quantum Blue® Infliximab: Health Canada Licence: 98838
Quantum Blue® Anti-Infliximab: Health Canada Licence: 105476
